Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoma and Thymic Carcinoma”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Testing effectiveness (Phase 2)Study completedNCT02623127
What this trial is testing

Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Seoul National University Hospital 25
Not applicableLooking for participantsNCT06301945
What this trial is testing

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymoma+1 more
Erasmus Medical Center 1,020
Testing effectiveness (Phase 2)Looking for participantsNCT05832827
What this trial is testing

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Who this might be right for
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan 35
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT04710628
What this trial is testing

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents

Who this might be right for
Metastatic Thymic CarcinomaThymoma Type B3
MedSIR 43
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00369889
What this trial is testing

Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

Who this might be right for
Thymic CancerThymoma
Indiana University 18
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Early research (Phase 1)Study completedNCT00921739
What this trial is testing

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung CancerThymoma+1 more
Duke University 24
Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Testing effectiveness (Phase 2)Ended earlyNCT00718809
What this trial is testing

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Who this might be right for
Invasive Thymoma and Thymic CarcinomaRecurrent Thymoma and Thymic CarcinomaStage III Thymoma+2 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)UnknownNCT03449173
What this trial is testing

Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)

Who this might be right for
Type B3 ThymomaThymic Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 56
Testing effectiveness (Phase 2)Looking for participantsNCT06019468
What this trial is testing

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Who this might be right for
Thymic Carcinoma
Shanghai Pulmonary Hospital, Shanghai, China 25
Early research (Phase 1)Looking for participantsNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Testing effectiveness (Phase 2)Study completedNCT00003283
What this trial is testing

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Who this might be right for
Thymoma and Thymic Carcinoma
Eastern Cooperative Oncology Group 38
Testing effectiveness (Phase 2)Study completedNCT00387868
What this trial is testing

Preoperative Treatment of Patients With High Risk Thymoma

Who this might be right for
Thymoma
Valley Health System 21
Testing effectiveness (Phase 2)Ended earlyNCT00818090
What this trial is testing

Paclitaxel and Cisplatin for Thymic Neoplasm

Who this might be right for
ThymomaThymic Carcinoma
Korean Cancer Study Group 39
Testing effectiveness (Phase 2)Study completedNCT01306045
What this trial is testing

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Small Cell LungCarcinoma, Thymic
National Cancer Institute (NCI) 647
Early research (Phase 1)Study completedNCT03102320
What this trial is testing

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

Who this might be right for
Neoplasms
Bayer 173
Load More Results